Terug
Dagbereik
€ 12,99
€ 13,82
52-Weeksbereik
€ 2,54
€ 26,95
Volume
1.179.540
50D / 200D Gem.
€ 16,97
/
€ 8,91
Vorige Slotkoers
€ 13,75
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -72,3 | 0,3 |
| P/B | 18,1 | 2,9 |
| ROE % | -32,6 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 31,80
+141.8%
Low: € 27,00
High: € 42,00
Forward WPA
-€ 0,69
Omzet Sch.
1,2 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,12
€ 0,10 – € 0,14
|
240 M | 2 |
| FY2029 |
-€ 0,46
-€ 0,53 – -€ 0,38
|
130 M | 4 |
| FY2028 |
-€ 0,64
-€ 1,56 – € 0,05
|
58 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -32,97M
PEG of 0,49 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-32,60%
ROIC-51,86%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,02
Current Ratio6,21
Interest Coverage0,00
Waardering
P/E Ratio
-72,27
P/B Ratio18,05
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -15,28M |
| ROE | -32,60% | ROA | -21,49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -32,97M |
| ROIC | -51,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 6,21 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -72,27 | P/B Ratio | 18,05 |
| P/S Ratio | N/A | PEG Ratio | 0,49 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,10B | Enterprise Value | 1,10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -15,28M | -62,29M | -27,03M | -41,31M | -43,24M |
| EPS (Diluted) | -0,53 | -1,02 | -0,56 | -0,89 | -1,03 |
| Gross Profit | -105.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -42,97M | -27,55M | -23,41M | -32,57M | -38,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 71,12M | 68,91M | 45,55M | 68,24M | 109,46M |
| Total Liabilities | 9,91M | 36,34M | 6,87M | 12,13M | 12,29M |
| Shareholders' Equity | 61,21M | 32,57M | 38,68M | 56,12M | 97,16M |
| Total Debt | 937.000,0 | 1,12M | 1,37M | 2,60M | 3,65M |
| Cash & Equivalents | 4,58M | 8,74M | 12,62M | 13,16M | 63,46M |
| Current Assets | 58,21M | 54,41M | 27,96M | 43,66M | 71,31M |
| Current Liabilities | 9,38M | 35,40M | 6,87M | 10,75M | 9,69M |